Belmar Pharmacy
“Prescriptions issued by clinicians on the platform are dispensed by the following US-licensed partner pharmacies: Belmar Pharmacy - 800-525-9473 - belmarpharmasolutions.com”
Pallas Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8/10
Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy
8.0
★★★★☆4/5
Pallas Health's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
$139first month
then $199/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at Pallas Health →
Compare top-rated alternatives ↓Prices checked August 2026
$199 and $299 a month are the averages on the compounded plans, with messaging, check-ins and provider care folded in, no membership charged on the side, and the figure unchanged at every dose. Mounjaro, Zepbound, Ozempic and Wegovy sell under their brand names next to compounded tirzepatide and semaglutide. Brentmoor, Inc. is the operator. Disclosure is unusually thorough here: NPIs you can verify against two named advising physicians, Lion MD as clinical partner, six pharmacy partners named, and all 50 states plus DC covered.
By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
GLP-1 from $199/moPrice shown up frontFlat across dosesIncludes medication + consultAll 50 statesPharmacy namedNo FDA warning letters found
Is Pallas Health legit?
Yes. Pallas Health is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 8.0/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Pallas Health promo or coupon code?
Pallas Health has no coupon code to enter. New patients are currently quoted $139 for the first month, then $199 a month, and the discount applies on its own. Coupon sites advertising a "Pallas Health promo code" are not a source we can vouch for.
See how Pallas Health compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Pallas Health
9.4/ 10
Verified partnerTrimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
★★★★★4.7/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Trimi Health review →★★★☆☆3.2/5
Editorial score · methodology
$149/mo
CompoundedSemaglutideTirzepatideOrforglipronGHK-Cu
Get StartedRead full ShedRx review →★★★★★4.5/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full bmiMD review →Pallas Health at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $199/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How Pallas Health scores
Six columns, each one computed from something Pallas Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.5/10$199/month is 8% above the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
10.0/10It names the pharmacy that fills its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves 51 of 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
6weighted dimensions
588sellers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Pallas Health
Last checked August 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Confirmed which compounding pharmacy fills the order, and its accreditation
- Checked FDA warning letters for Pallas Health
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Pallas Health involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Pallas Health shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Belmar Pharmacy fills the prescriptions, and Pallas Health names it publicly, which most sellers do not.
- 3The monthly price includes the medication, clinician visits and shipping.
Price shown before you start
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- Pallas Health serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Cancelling Pallas Health
Taken from the terms Pallas Health publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Full refund if a clinician declines or the order is unfulfilled; otherwise minus processing plus a $5 fee
- Early-termination fee
- None
GLP-1 medications Pallas Health offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Peptides Pallas Health offers
Pallas Health sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Compounded plan, billed $597 every 12 weeks (not monthly)Compounded
$199$139/mo
Save 30% right nowsemaglutide
$139 for the first month, then $597 every 12 weeks, which Pallas advertises as a $199/mo average. Same price at every dose. Provider care and check-ins included.
Compounded plan, billed $897 every 12 weeks (not monthly)Compounded
$299$179/mo
Save 40% right nowtirzepatide
$179 for the first month, then $897 every 12 weeks, advertised as a $299/mo average. Same price at every dose.
Check the price yourself before you pay
Every figure here was read off Pallas Health's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Pallas Health compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that Pallas Health routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
Strive Pharmacy
“Strive Pharmacy - 855-405-5993 - strivepharmacy.com”
Epiq Scripts
“Epiq Scripts - 833-654-3553 - epiqscripts.com”
Casa Pharma Rx
“Casa Pharma Rx - 877-937-6868 - casapharmarx.com”
The Pharmacy Hub
- License footprint
- 1 states: FL
“The Pharmacy Hub - 888-958-1382 - thepharmacyhub.com”
Foothills Pharmacy
“Foothills Pharmacy - 480-496-4444 - foothillspharmacy.com”
In its favor
- Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- Names 6 pharmacies that fill its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Pallas Health
Against it
- Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Pallas Health charges
The figure Pallas Health leads with is $139, and it is a first-month rate. From month two the price is $199/month, which is the number to plan around. There is nothing wrong with an introductory offer; it just is not the price of staying on the medication.
- Compounded semaglutide: $139 first month, then $199/month
- Compounded tirzepatide: $179 first month, then $299/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so Pallas Health's $199 lands mid-market. Price is unlikely to be the deciding factor.
RNK Health dispenses semaglutide and tirzepatide from $197/month, which makes it the fair comparison to run before you commit here.
What Pallas Health dispenses
Pallas Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
Safety and disclosure
Pallas Health tells you its price before you start the medical questionnaire, that it treats patients in all 50 states, and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to Pallas Health. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Pallas Health bills your plan before you start.
It fits if
- you want the price to stop moving as your dose climbs
- you want a cheap way to find out whether the medication suits you before committing
- you need access wherever you live
Our read
Pallas Health is a cheap way to start and an ordinary way to continue. Use the $139 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $199/month before you let it renew twice. HumeCare+ is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Pallas Health's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Score: 8/10Best for: knowing which pharmacy fills the vial: it names Belmar PharmacyFrom: $139/mo
Before you pay Pallas Health
Starting at $139 a month. Check today's price, then start the intake.
Where Pallas Health is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare Pallas Health head to head
The sellers closest to Pallas Health on medication and price.
Frequently Asked Questions
$199 and $299 a month are the averages on the compounded plans, with messaging, check-ins and provider care folded in, no membership charged on the side, and the figure unchanged at every dose. Mounjaro, Zepbound, Ozempic and Wegovy sell under their brand names next to compounded tirzepatide and semaglutide. Brentmoor, Inc. is the operator. Disclosure is unusually thorough here: NPIs you can verify against two named advising physicians, Lion MD as clinical partner, six pharmacy partners named, and all 50 states plus DC covered. We rate it 8.0/10 overall.
The standing rate at Pallas Health is $199 a month. The $139 figure is a first month, not what you pay from month two. Cost also moves with the medication and the dose, so read the row in the pricing table above that matches yours.
Pallas Health says it treats patients in all 50 states.
Pallas Health sells semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro). Every dose it lists is compounded.
Pallas Health lists compounded GLP-1s only. A licensed compounding pharmacy prepares them: same active ingredient as the brand drug, lower cash price, and no FDA approval of the finished product. That last part is the one readers underestimate, and the review above says why.
Check whether Pallas Health bills your insurance before you sign up. It also takes FSA and HSA cards. Compounded GLP-1s are rarely covered by insurance, so plan on paying the listed cash price.
Pallas Health says the price covers medication, the clinician visit and shipping. The strip near the top of this review shows what is included and what is not.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. New patients are currently quoted $139 for the first month. Pallas Health runs that whole sequence on its own site.
We found no FDA warning letters issued to Pallas Health. Before you buy, weigh these: Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare. Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality. None of them rules Pallas Health out, but each is worth settling before you pay.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Pallas Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Pallas Health's current pricing
Plans start at $139 a month. Whether you qualify is a clinician's decision, made after your intake.
Not sold on Pallas Health?
Vetted alternatives